Jenburkt Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jenburkt Pharmaceuticals Ltd. on BSE

Load latest

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1328.40

-0.96%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

The Board of Directors of the Company recomended a dividend of Rs.18/- (180%) per equity share of Rs. 10/- each on 4413300 equity shares of the Company, for the Financial year 2024-25, subject to the approval of members at the ensuing 40th Annual General Meeting of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1328.40

-0.96%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Re-appointment of Chairman and Managing Director of the Company, Subject to the Approval of the Members at the ensuing 40th Annual General Meeting of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1328.40

-0.96%

Result

Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Audited Financial Results For The Quarter And Financial Year …

BSE India

Standalone Audited Financial Results for the Quarter and Financial Year Ended on 31st March, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1328.40

-0.96%

Board Meeting

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting Held on 20th May, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1328.40

-0.96%

Annual Report

Annual report for Jenburkt Pharmaceuticals Ltd. for FY-2025

None

pdf

Jenburkt Pharmaceuticals Ltd.

12 May 2025, 07:01PM

1328.40

-0.96%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you about the change in Senior Management Personnel of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

12 May 2025

1328.40

-0.96%

Board Meeting

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Taking On Record The Audited Financial …

BSE India

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve the audited financial results for the quarter and financial year ended on 31st March, 2025 and recommend dividend, if any.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Apr 2025

1328.40

-0.96%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Disclosures Pursuant To SEBI Circular Dated 10Th August, 2021 :"Not …

BSE India

pursuant to SEBI Circular dated 10th August, 2021, we hereby confirm that for the financial year ended 31st March, 2025, Jenburkt Pharmaceuticals limited is " not a large corporate" as per the applicability criteria mentioned in clause 2.1 f chapter XII therein.

pdf